Filing Details

Accession Number:
0001567619-21-002501
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-08 19:06:03
Reporting Period:
2021-02-05
Accepted Time:
2021-02-08 19:06:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628171 Revolution Medicines Inc. RVMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1246842 A Mark Goldsmith C/O Revolution Medicines, Inc.
700 Saginaw Drive
Redwood City CA 94063
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-05 15,000 $1.12 15,744 No 4 M Direct
Common Stock Disposition 2021-02-05 15,000 $55.00 744 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-02-05 15,000 $0.00 15,000 $1.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
63,486 2028-04-19 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 35,953 Indirect Trust
Common Stock 35,953 Indirect Trust
Common Stock 247,093 Indirect Trust
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  2. Includes 744 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2020.
  3. Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
  4. Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
  5. Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
  6. This option is early exercisable. One forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary measured from March 29, 2018 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.